Spain: Grifols accelerates expansion plans with acquisition of Biotest

Grifols, a Spanish multinational pharmaceutical and chemical manufacturer specializing in plasma-derived medicines, has completed the acquisition of 100% of the share capital of Tiancheng (Germany) Pharmaceutical Holdings, a German company that holds 89.88% of the ordinary shares and 1.08% of the preferred shares of Biotest, a European healthcare company specialized in hematology and clinical immunology….

You must be a HMI Subscriber to view this content.

Subscribe Now »